From: Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients
Term | GO accession | ExpCount | Count | Odds ratio | P-value |
---|---|---|---|---|---|
Extracellular region | GO:0005576 (CC) | 42 | 76 | 2.06 | 2.27E-07 |
Cytokine activity | GO:0005125 (MF) | 4 | 15 | 4.18 | 1.12E-05 |
Receptor binding | GO:0005102 (MF) | 21 | 41 | 2.19 | 1.85E-05 |
Extracellular region part | GO:0044421 (CC) | 22 | 42 | 2.06 | 5.17E-05 |
Immune response | GO:0006955 (BP) | 17 | 35 | 2.19 | 6.74E-05 |
Extracellular space | GO:0005615 (CC) | 17 | 34 | 2.17 | 9.00E-05 |
Immune system process | GO:0002376 (BP) | 28 | 48 | 1.90 | 1.19E-04 |
Regulation of lymphocyte activation | GO:0051249 (BP) | 5 | 14 | 3.30 | 2.19E-04 |
Defense response | GO:0006952 (BP) | 18 | 33 | 2.01 | 4.38E-04 |
Regulation of lymphocyte proliferation | GO:0050670 (BP) | 2 | 9 | 4.27 | 5.07E-04 |
Lymphocyte proliferation | GO:0046651 (BP) | 3 | 10 | 3.89 | 5.08E-04 |
T-cell proliferation | GO:0042098 (BP) | 2 | 8 | 4.75 | 5.37E-04 |
Regulation of mononuclear cell proliferation | GO:0032944 (BP) | 2 | 9 | 4.23 | 5.44E-04 |
Cytokine receptor binding | GO:0005126 (MF) | 4 | 12 | 3.33 | 5.48E-04 |
Mononuclear cell proliferation | GO:0032943 (BP) | 3 | 10 | 3.82 | 5.76E-04 |
Regulation of leukocyte activation | GO:0002694 (BP) | 5 | 14 | 2.97 | 5.90E-04 |
Regulation of leukocyte proliferation | GO:0070663 (BP) | 2 | 9 | 4.14 | 6.26E-04 |
Leukocyte proliferation | GO:0070661 (BP) | 3 | 10 | 3.72 | 6.92E-04 |
Regulation of cell activation | GO:0050865 (BP) | 5 | 14 | 2.82 | 9.40E-04 |
Regulation of T-cell proliferation | GO:0042129 (BP) | 2 | 7 | 4.93 | 9.56E-04 |